Randomized Study of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients
A Randomized Study of 4 vs. 8 Cycles of Velcade-based Regimen With Autologous Stem Cell Transplantation in Newly-diagnosed Myeloma Patients
Sponsor: Shanghai Jiao Tong University School of Medicine
Terminated
Very slow recruitment
Other terminated trials from Shanghai Jiao Tong University School of Medicine
- Carcinoma, Squamous Cell · Phase PHASE2 · Jul 2023
- Breast Neoplasm · Phase PHASE2 · Jun 2021
- BCT Rate · Phase PHASE2 · Jun 2020
- Cognition Disorders · Nov 2019
- Breast Cancer · Phase PHASE3 · Oct 2015
See all terminations from Shanghai Jiao Tong University School of Medicine
This PHASE2/PHASE3 trial investigates Multiple Myeloma and is currently terminated or withdrawn. Shanghai Jiao Tong University School of Medicine leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE2/PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE2/PHASE3
Phase: PHASE2_PHASE3 → PHASE2/PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE2_PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE2_PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE2_PHASE3
First recorded
Aug 2009
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Shanghai Jiao Tong University School of Medicine
For direct contact, visit the study record on ClinicalTrials.gov .